
- Volume 0 0
FEDS WARN AGAINST COUNTERFEIT DRUGS AT 24 INTERNET PHARMACIES
<p>Federal drug regulators are warning the public to avoid 2 dozen Internet pharmacy sites that officials say may be involved in the distribution of counterfeit prescription medicines.</p>
<p>FDA officials obtained evidence that at least 3 of the apparently related Web sites were distributing counterfeit versions of Hoffmann-La Roche’s antiobesity drug Xenical 120 mg. Tests by Roche found that none of the capsules ordered from the Internet sites contained orlistat, the active ingredient in authentic Xenical.</p>
<p>Instead, the laboratory analysis confirmed that most of the Internet drugs were composed of only talc and starch. Worse yet, at least one capsule contained sibutramine—an ingredient in Abbott’s competing drug, Meridia.</p>
<p>Roche identified the 2 Web sites involved in this incident as <a href="
<p>Both of these sites appear to be associated with a larger group of 24 Internet sites under investigation for alleged distribution of counterfeit oseltamivir phosphate (Tamiflu) and counterfeit tadalafil (Cialis).</p>
<p>“At this point, it appears that these Web sites are operated from outside of the United States,” said FDA officials. “Consumers should be wary, if there is no way to contact the Web site pharmacy by phone, if prices are dramatically lower than the competition, or if no prescription from your doctor is required.”</p>
<p>A listing of the 24 Web sites can be found at <a href="
Articles in this issue
over 18 years ago
otc Product Newsover 18 years ago
Pregnancy OK with Rheumatoid Arthritisover 18 years ago
OUT-OF-RANGE INRs COMMON AMONG WARFARIN PATIENTS IN ERover 18 years ago
case STUDIESover 18 years ago
THE DEBATE CONTINUES ON LENGTH OF THERAPYover 18 years ago
METABOLIC SYNDROME MAY CONTRIBUTE TO RISK OF VTEover 18 years ago
can you READ these Rxs?over 18 years ago
Reducing Drug Interaction Alerts: Not So Easyover 18 years ago
compounding HOTLINEover 18 years ago
Meeting the Needs of the Hospice PatientNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.